LIPOSOME-BASED EYE DROPS AND USE THEREOF FOR IN VIVO EVALUATION OF THE DRUG EFFICACY OF MEDICAL AND SURGICAL ANTI-GLAUCOMA THERAPY

摘要

Eye drops are described consisting of a visco-elastic dispersion comprising chondroitin sulfate and optionally sodium hyaluronate, a vitreo-retinal dye and an antiglaucoma drug of the above type, conveyed by a liposome-based nano-carrier to be administered topically as eye drops to highlight the drug efficacy in vivo using direct visualization of the conventional aqueous humor outflow pathway.